Loading...
Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer
Gastric cancer remains third leading cause of global cancer mortality and is the fifth most common type of cancer in the United States. A select number of gastric cancers harbor alterations in EGFR and/or have amplification/overexpression in the HER2; 2–35 and 9–38%, respectively. The advent of next...
Saved in:
| Published in: | Front Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7418523/ https://ncbi.nlm.nih.gov/pubmed/32850413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01312 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|